Stocktoria
BECTON DICKINSON & CO BDX
NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1963-09-25
BECTON DICKINSON & CO financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.8B | $20.2B | $19.4B | $18.9B | $19.1B | $16.1B | $17.3B | $16.0B | $12.1B | $12.5B |
| Gross profit | — | — | — | — | — | $7.6B | $8.3B | $7.3B | $5.9B | $6.0B |
| R&D expense | $1.3B | $1.2B | $1.2B | $1.3B | $1.3B | $1.0B | $1.1B | $1.0B | $770.0M | $828.0M |
| SG&A expense | $5.3B | $4.9B | $4.7B | $4.7B | $4.7B | $4.2B | $4.3B | $4.0B | $2.9B | $3.0B |
| Operating income | $2.6B | $2.4B | $2.1B | $2.3B | $2.2B | $912.0M | $1.8B | $1.5B | $1.5B | $1.4B |
| Interest expense | $613.0M | $528.0M | $452.0M | $398.0M | $469.0M | $528.0M | $639.0M | $706.0M | $521.0M | $388.0M |
| Income tax | $203.0M | $300.0M | $132.0M | $148.0M | $88.0M | $62.0M | -$57.0M | $862.0M | -$124.0M | $97.0M |
| Net income | $1.7B | $1.7B | $1.5B | $1.8B | $2.1B | $874.0M | $1.2B | $311.0M | $1.1B | $976.0M |
| EPS (diluted) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.94 | $0.60 | $4.60 | $4.49 |
| Operating cash flow | $3.4B | $3.8B | $3.0B | $2.5B | $4.6B | $3.5B | $3.3B | $2.9B | $2.5B | $2.6B |
| Free cash flow | $2.7B | $3.1B | $2.1B | $1.5B | $3.5B | $2.8B | $2.4B | $2.0B | $1.8B | $1.9B |
| Cash & equivalents | $567.0M | $1.7B | $1.4B | $1.0B | $2.3B | $2.8B | $536.0M | $1.1B | $14.2B | $1.5B |
| Inventory | $3.1B | $3.8B | $3.3B | $3.2B | $2.7B | $2.7B | $2.6B | $2.5B | $1.8B | $1.7B |
| Total assets | $55.3B | $57.3B | $52.8B | $52.9B | $53.9B | $54.0B | $51.8B | $53.9B | $37.7B | $25.6B |
| Shareholders' equity | $25.4B | $25.9B | $25.8B | $25.3B | $23.7B | $23.8B | $21.1B | $21.0B | $12.9B | $7.6B |
Growth · year-over-year · Revenue CAGR 6.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.2% | +4.2% | +2.7% | -1.4% | +19.0% | -7.0% | +8.2% | +32.2% | -3.1% | +21.4% |
| Net income growth | -1.6% | +14.9% | -16.6% | -15.0% | +139.4% | -29.1% | +296.5% | -71.7% | +12.7% | +40.4% |
| EPS growth | -0.7% | +18.6% | -16.0% | -14.2% | +152.8% | -31.2% | +556.7% | -87.0% | +2.4% | +34.0% |
| Free cash flow growth | -14.4% | +47.4% | +41.3% | -56.6% | +24.7% | +16.7% | +20.5% | +8.1% | -2.3% | +64.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.